TP53 and neoplasm: The structures of ASPP2 in complex with the p53 and p73 tumour suppressors reveal a direct interaction between the ASPP2 SH3 domain and the p53/p73 DNA binding domains centred on the cancer hotspot residues p53R248 and p73R268 56,57.